rs4818

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000754.4(COMT):​c.408C>G​(p.Leu136Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.375 in 1,612,472 control chromosomes in the GnomAD database, including 116,267 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 8487 hom., cov: 33)
Exomes 𝑓: 0.38 ( 107780 hom. )

Consequence

COMT
NM_000754.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7O:2

Conservation

PhyloP100: 0.271
Variant links:
Genes affected
COMT (HGNC:2228): (catechol-O-methyltransferase) Catechol-O-methyltransferase catalyzes the transfer of a methyl group from S-adenosylmethionine to catecholamines, including the neurotransmitters dopamine, epinephrine, and norepinephrine. This O-methylation results in one of the major degradative pathways of the catecholamine transmitters. In addition to its role in the metabolism of endogenous substances, COMT is important in the metabolism of catechol drugs used in the treatment of hypertension, asthma, and Parkinson disease. COMT is found in two forms in tissues, a soluble form (S-COMT) and a membrane-bound form (MB-COMT). The differences between S-COMT and MB-COMT reside within the N-termini. Several transcript variants are formed through the use of alternative translation initiation sites and promoters. [provided by RefSeq, Sep 2008]
MIR4761 (HGNC:41591): (microRNA 4761) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 22-19963684-C-G is Benign according to our data. Variant chr22-19963684-C-G is described in ClinVar as [Benign]. Clinvar id is 256786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-19963684-C-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.271 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.391 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COMTNM_000754.4 linkc.408C>G p.Leu136Leu synonymous_variant Exon 4 of 6 ENST00000361682.11 NP_000745.1 P21964-1A0A140VJG8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COMTENST00000361682.11 linkc.408C>G p.Leu136Leu synonymous_variant Exon 4 of 6 1 NM_000754.4 ENSP00000354511.6 P21964-1

Frequencies

GnomAD3 genomes
AF:
0.324
AC:
49164
AN:
151960
Hom.:
8492
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.206
Gnomad AMI
AF:
0.306
Gnomad AMR
AF:
0.304
Gnomad ASJ
AF:
0.471
Gnomad EAS
AF:
0.325
Gnomad SAS
AF:
0.311
Gnomad FIN
AF:
0.301
Gnomad MID
AF:
0.424
Gnomad NFE
AF:
0.395
Gnomad OTH
AF:
0.359
GnomAD3 exomes
AF:
0.338
AC:
84214
AN:
249446
Hom.:
14967
AF XY:
0.346
AC XY:
46860
AN XY:
135238
show subpopulations
Gnomad AFR exome
AF:
0.197
Gnomad AMR exome
AF:
0.213
Gnomad ASJ exome
AF:
0.460
Gnomad EAS exome
AF:
0.323
Gnomad SAS exome
AF:
0.321
Gnomad FIN exome
AF:
0.309
Gnomad NFE exome
AF:
0.395
Gnomad OTH exome
AF:
0.370
GnomAD4 exome
AF:
0.380
AC:
555409
AN:
1460394
Hom.:
107780
Cov.:
58
AF XY:
0.380
AC XY:
276355
AN XY:
726524
show subpopulations
Gnomad4 AFR exome
AF:
0.197
Gnomad4 AMR exome
AF:
0.222
Gnomad4 ASJ exome
AF:
0.460
Gnomad4 EAS exome
AF:
0.309
Gnomad4 SAS exome
AF:
0.320
Gnomad4 FIN exome
AF:
0.314
Gnomad4 NFE exome
AF:
0.401
Gnomad4 OTH exome
AF:
0.377
GnomAD4 genome
AF:
0.323
AC:
49172
AN:
152078
Hom.:
8487
Cov.:
33
AF XY:
0.320
AC XY:
23760
AN XY:
74316
show subpopulations
Gnomad4 AFR
AF:
0.206
Gnomad4 AMR
AF:
0.304
Gnomad4 ASJ
AF:
0.471
Gnomad4 EAS
AF:
0.324
Gnomad4 SAS
AF:
0.311
Gnomad4 FIN
AF:
0.301
Gnomad4 NFE
AF:
0.395
Gnomad4 OTH
AF:
0.359
Alfa
AF:
0.375
Hom.:
3482
Bravo
AF:
0.317
Asia WGS
AF:
0.311
AC:
1081
AN:
3478
EpiCase
AF:
0.416
EpiControl
AF:
0.409

ClinVar

Significance: Benign
Submissions summary: Benign:7Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:2
May 04, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 19641441, 9323320, 30218069, 25766270) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

methamphetamine use disorder Other:1
Jan 16, 2023
Beijing Key Laboratory of Neuropsychopharmacology, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology
Significance: Uncertain risk allele
Review Status: no assertion criteria provided
Collection Method: case-control

- -

Tramadol response Other:1
Apr 28, 2018
Bruce Budowle Laboratory, University of North Texas Health Science Center
Significance: drug response
Review Status: no assertion criteria provided
Collection Method: research

- T:M1 = postmortem ratio or tramadol to O-desmethyltramadol; t-MP = model-based clustered metabolizer phenotype inferred from T:M1

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
3.0
DANN
Benign
0.62
RBP_binding_hub_radar
1.0
RBP_regulation_power_radar
3.2

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4818; hg19: chr22-19951207; COSMIC: COSV52889002; COSMIC: COSV52889002; API